GeneDx Corp.

88.50
-3.70 (-4.01%)
At close: Mar 31, 2025, 3:59 PM
88.00
-0.56%
After-hours: Mar 31, 2025, 07:19 PM EDT

GeneDx Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
Revenue 305.45M 202.57M 234.69M 212.19M 179.32M 196.17M
Cost of Revenue 111.05M 141.94M 261.44M 228.8M 175.3M 113.39M
Gross Profit 194.4M 60.62M -26.75M -16.6M 4.03M 82.78M
Operating Income -23.21M -163.66M -667.65M -446.15M -241.99M -30.41M
Interest Income n/a 1.11M 2.54M 79K 506K 988K
Pretax Income -52.63M -176.69M -598.03M -245.39M -241.34M -29.7M
Net Income -52.29M -175.77M -548.98M -245.39M -246.44M -30.99M
Selling & General & Admin 168.48M 194.71M 338.24M 318.73M 163.93M 68.84M
Research & Development 45.72M 58.27M 86.2M 105.16M 72.7M 34.91M
Other Expenses n/a -28.69M 6.31M 5.66M 9.39M 9.45M
Operating Expenses 214.2M 224.28M 430.76M 429.55M 246.02M 113.2M
Interest Expense -3.03M n/a 3.21M 2.83M 2.47M 783K
Selling & Marketing Expenses 67.37M 60.96M 134.91M 112.74M 63.18M 39.35M
Cost & Expenses 325.26M 366.23M 692.2M 658.34M 421.32M 226.59M
Income Tax -343K -926K -49.05M 21.57M 5.1M 1.29M
Shares Outstanding (Basic) 26.89M 24.31M 10.24M 3.28M 155.48 7.28M
Shares Outstanding (Diluted) 26.89M 24.31M 10.24M 3.28M 1.68M 1.68M
EPS (Basic) -1.94 -7.23 -53.63 -74.93 -1.58M -4.26
EPS (Diluted) -1.94 -7.23 -53.63 -74.93 -146.94 -18.48
EBITDA -23.21M -136.46M -398.2M -219.19M -224.73M -22.51M
Depreciation & Amortization n/a 33.73M 63.03M 23.36M 14.13M 6.41M